Skoči na glavni sadržaj

Izvorni znanstveni članak

https://doi.org/10.3325/cmj.2022.63.56 4

No increase in GFAP and S-100B in very preterm infants with mild periventricular leukomalacia or intraventricular hemorrhage: a pilot study

Maša Koce ; University Medical Centre Ljubljana, Ljubljana, Slovenia
Aleš Jerin ; Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Ljubljana, Slovenia
Domen Plut ; Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Vanja Erčulj ; Rho Sigma Research & Statistics, Ljubljana, Slovenia
Lilijana Kornhauser Cerar ; Rho Sigma Research & Statistics, Ljubljana, Slovenia
Stefan Grosek ; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia *

* Dopisni autor.


Puni tekst: engleski pdf 150 Kb

str. 564-569

preuzimanja: 103

citiraj


Sažetak

Aim To determine the serum levels of glial fibrillary acidic
protein (GFAP) and S-100B in very preterm infants with and
without periventricular leukomalacia (PVL) and/or intra
-
ventricular hemorrhage (IVH).
Methods The study enrolled preterm infants born be
-
tween 23 and 32 weeks of gestation admitted to the Neo
-
natal Intensive Care Unit, University Medical Center Ljublja
-
na. PVL and IVH were determined with cranial ultrasound.
Peripheral blood was collected in the first 24 hours after
delivery and once between days 4 to 7. GFAP and S-100B
concentrations were measured in serum samples. Infants
with PVL or IVH were compared with infants without PVL
or IVH.
Results Of 40 patients (mean gestational age 29.4 weeks),
7 had IVH and/or PVL. S-100B was detectable in peripheral
blood in all patients at every measurement. In the group
with IVH or PVL, the median S-100B at the first sampling
was 0.43 (IQR 0.29-0.60) ng/mL, and 0.40 (IQR 0.33-1.01)
ng/mL at the second sampling. In the group without PVL
or IVH, it was 0.40 (IQR 0.29-0.6) ng/mL at the first sampling
and 0.43 (IQR 0.34-0.62) ng/mL at the second sampling.
The median GFAP was 0 regardless of the group and sam
-
pling time. The groups did not significantly differ in serum
GFAP or S-100B levels.
Conclusion Peripheral blood levels of GFAP and S-100B
were not significantly increased in very preterm infants
that developed PVL or IVH. The predictive value of GFAP
and S-100B as biomarkers of neonatal brain injury should
be further explored in a larger cohort of neonates with
more extensive IVH or PVL.

Ključne riječi

Hrčak ID:

331078

URI

https://hrcak.srce.hr/331078

Datum izdavanja:

15.12.2022.

Posjeta: 248 *